0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Recombinant Proteins & Antibodies

Immune Checkpoint Proteins

ACROBiosystems has developed an exclusive immune checkpoint protein collection, The consistency and excellent performance of our proteins are confirmed by a variety of assays.

CD3 Proteins

ACROBiosystems has developed a series of homogeneous CD3 proteins with good bioactivity. They are verified as 1:1 heterodimers by nonreductive electrophoresis and MALS as well.

Targets for ADCs

ACROBiosystems has developed a series of products with different species and tags for a variety of hot targets. It is suitable for immune, antibody screening, SPR, cell activity detection and other experiments, and all SPR&BLI protocols are available for free.

Targets of CAR-T Cell Therapy

We also supply difficult-to-express proteins such as BCMA, CD19, ROR1, and EGFRVIII.

Fc Receptor Proteins

ACROBiosystems offers a comprehensive collection of recombinant Fc receptor proteins, including their common variants, to help expedite your mAb development.

PE-labeled protein

ACROBiosystems has developed an exclusive collection of PE-labeled proteins by a proprietary site-specific conjugation technology, and these proteins are ideal for detecting CAR expression.

MABSOL® Biotinylated Proteins

The Mabsol biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.

VEGF Proteins

ACROBiosystems has developed a variety of VEGF proteins with different molecules, subtypes, species, and tags to help expedite your antibody drug development. All SPR&BLI protocols are available for free.

Reagents for vaccine development

ACROBiosystems has developed a series of critical reagents for COVID-19 vaccine development and evaluation,including proteins, antibodies and kits. These featured products are suitable for IgG/M antibody titer detection, neutralizing antibody titer detection and antigen titer detection.

SARS-CoV-2 proteins&kits

High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.

Reagents for COVID-19 diagnostics

ACROBiosystems has developed a serial of high-quality antigen and antibody reagents, including super stable trimeric S protein, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity verified by inactivated virus samples.

SARS-CoV-2 Related Kit Products

ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.

Newly Added Products

Spike Mutants from SARS-CoV-2 Variant B.1.1.7

ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.

PE- SLAMF7 Protein

The newly launched PE-labeled SLAMF7 protein is a powerful tool for detecting anti-SLAMF7 CAR expression by one step staining with high sensitivity and high specificity. FITC and Biotin-labeled SLAMF7 proteins are also available.

News Center

Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied
2021/05/11
Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied
After the sharp rise in COVID-19 cases and deaths in India over recent weeks, at least 20 countries have imposed travel bans and restrictions to and from India. The world again stands at a crossroad of the viral evolution.
Learn more
The Top Risk of CAR-T Therapy: Cytokine Release Syndrome (CRS) ——Assessment, grading and management of CRS
2021/02/02
The Top Risk of CAR-T Therapy: Cytokine Release Syndrome (CRS) ——Assessment, grading and management of CRS
In recent years, CAR-T cell therapy brings the hope of a cure to many cancer patients. Despite the outstanding effectiveness, the toxicity called cytokine release syndrome (CRS) is a severe problem.
Learn more
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
2021/05/10
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
Multiple SARS-CoV-2 variants are emerging and circulating globally; the battle against COVID-19 pandemic is still challenging. Recently, ACROBiosystems donated SARS-CoV-2 mutant proteins to BEI Resources, a NIAID funded bioresource program, joining in the collective effort in attacking SARS-CoV-2 va
Learn more
The 4th Annual Sanofi Global Analytical Symposium
2021/06/15 - 2021/06/16
The 4th Annual Sanofi Global Analytical Symposium
Speaker: Prajwal Paudel and more
Time: JUNE 15-16.2021
Learn more

This web search service is supported by Google Inc.

totop